Douglas Holtzman, Chief Scientific Officer at Icosavax, Inc. (ICVX), sold 4,871 shares at $10.69 ($50K) on 2023-02-13, disclosed to the SEC on 2023-02-15.
Scheduled sale ($50k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.69 | 1,522 | $16K | 32.3% |
| 2 | $10.17 | 3,349 | $34K | 67.7% |
| Total | $10.33 avg | 4,871 | $50K | 100% |
| Filing → |
| ICVX | SELL | 2022-12-16 | $438K | — | Filing → |
| ICVX | SELL | 2022-08-02 | $131K | — | Filing → |